Journals / Van Tıp Dergisi / 2019 / Cilt: 26 - Sayı: 1

Mucormycosis In A Patient With Acute Lymphoblastic Leukemia: A Case Report

Akut Lenfoblastik Lösemi Tanılı Hastada Gelişen Mukormikozis: Olgu Sunumu

Pages
120–124
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In the treatment of this form, it is recommended to apply amphotericin B and surgery together.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Mucormycosis is a rare, emerging fungal infection, with high morbidity and mortality.
📊
Key Findings & Data:Rhino-orbito-cerebral form is common.
💡
Conclusion & Impact:In the treatment of this form, it is recommended to apply amphotericin B and surgery together.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Mucormycosis is a rare, emerging fungal infection, with high morbidity and mortality. Rhino-orbito-cerebral form is common. In the treatment of this form, it is recommended to apply amphotericin B and surgery together. However, despite these treatments, mortality is very high. We present a case of mucormycosis which we treated successfully with surgery for three times and simultaneously intravenous and nasal amphotericin B liopozomal application in our patient with acute lymphoblastic leukemia.

Özet

Mukormikoz, yüksek morbidite ve mortaliteye sahip, nadir görülen bir mantar enfeksiyonudur. Rino-orbito-serebral formu sık görülmektedir. Bu formun tedavisinde amfoterisin B ve cerrahinin birlikte uygulanması önerilmektedir. Ancak bu tedavilere rağmen mortalitesi oldukça yüksektir. Bizde akut lenfoblastik lösemi tanılı hastamızda gelişen 3 kez cerrahi uyguladığımız eş zamanlı hem intravenöz hemde burun içi lipozomal amfoterisin B uygulayarak başarılı bir şekilde tedavi ettiğimiz mukormikozis olgusunu sunduk.

🔖

Cite This Article

DEMİRCİOĞLU, S., DOĞAN, A., EKİNCİ, Ö., DÜZENLİ, U., BARAN, A. İ., BAYRAM, İ., DEMİR, C. (2019). Mucormycosis In A Patient With Acute Lymphoblastic Leukemia: A Case Report. Van Tıp Dergisi, Cilt: 26 - Sayı: 1, 120–124. https://ajindex.com/articles/333666

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Kauffman CA, Malani AN. Zygomycosis: an emerging fungal infection with new options for management. Curr Infect Dis Rep 2007; 9(6): 435-440
  2. Ferguson BJ. Mucormycosis of the nose and paranasal sinuses. Otolaryngol Clin North Am 2000; 33(2): 349-365
  3. Greenberg RN, Scott LJ, Vaughn HH, Ribes JA. Zygomycosis (mucormycosis): emerging clinical importance and new treatments. Curr Opin Infect Dis 2004; 17(6): 517-525
  4. Trifilio SM, Bennett CL, Yarnold PR, McKoy JM, Parada J, Mehta J, et al. Breakthrough zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hematopoietic stem-cell transplants or intensive chemotherapy. Bone Marrow Transplant 2007; 39(7): 425-429
  5. Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. 2005; 41(5): 634-653
  6. Cocanour CS, Miller-Crotchett P, Reed RL, 2nd, Johnson PC, Fischer RP. Mucormycosis in trauma patients. J Trauma 1992; 32(1): 12- 15
  7. Nagy-Agren SE, Chu P, Smith GJ, Waskin HA, Altice FL. Zygomycosis (mucormycosis) and HIV infection: report of three cases and review. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 10(4): 441-449
  8. Petrikkos G, Skiada A, Lortholary O, Roilides E, Walsh TJ, Kontoyiannis DP. Epidemiology and clinical manifestations of mucormycosis. Clin infect dis: an official publication of the Infectious Diseases Society of America 2012; 54 (1): 23-34
  9. Farmakiotis D, Kontoyiannis DP. Mucormycoses. Infect Dis Clin North Am. 2016; 30(1): 143-163
  10. Maertens J, Demuynck H, Verbeken EK, Zachee P, Verhoef GE, Vandenberghe P, et al. Mucormycosis in allogeneic bone marrow transplant recipients: report of five cases and review of the role of iron overload in the pathogenesis. Bone Marrow Transplant 1999; 24(3): 307-312
  11. Boelaert JR, Van Cutsem J, de Locht M, Schneider YJ, Crichton RR. Deferoxamine augments growth and pathogenicity of Rhizopus, while hydroxypyridinone chelators have no effect. Kidney int 1994; 45(3): 667- 671
  12. Skiada A, Pagano L, Groll A, Zimmerli S, Dupont B, Lagrou K, et al. Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007. Clin Microbiol Infect 2011; 17(12): 1859-1867
  13. Martinez EJ, Cancio MR, Sinnott JTt, Vincent AL, Brantley SG. Nonfatal gastric mucormycosis in a renal transplant recipient. S